Amir Shahlaee, MD
Allergy & Immunology · Annandale, VANPI 1649214529
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,745 of the $18,627 with a category attached, or 63.1%. 34 manufacturers reported payments, led by Pfizer at 32.0% of the total. Reporting peaked in 2019 at $8,210 and has fallen 78.6% since, to $1,754 in 2025.
Across 450 payments — averaging $41.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- AstraZeneca$2K
- Blueprint Medicines Corporation$2K
- GSK$2K
- Sanofi$1K
- Genentech USA, Inc.$806
- plus $4K from 28 others
What the payments were for
- Consulting fees$200%
- Speaking & faculty fees$6,43835%
- Travel & lodging$100%
- Food & beverage$11,74563%
- Education$4142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 46 | $5,961 |
| AstraZeneca | 91 | $2,463 |
| Blueprint Medicines Corporation | 6 | $1,814 |
| GSK | 84 | $1,807 |
| Sanofi | 46 | $1,399 |
| Genentech USA, Inc. | 23 | $806 |
| Optinose US, Inc. | 15 | $486 |
| Novartis | 20 | $469 |
| Alk-abello, Inc | 7 | $437 |
| Kaleo, Inc. | 16 | $418 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $391 |
| Regeneron Healthcare Solutions, Inc. | 10 | $324 |
| Sanofi-aventis U.S. LLC | 6 | $315 |
| Teva Pharmaceuticals USA, Inc. | 9 | $279 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $238 |
| CSL Behring | 7 | $191 |
| Grifols USA, LLC | 9 | $148 |
| Amgen(2 entities) | 7 | $137 |
| Bio Products Laboratory USA, Inc. | 5 | $96 |
| Incyte Corporation | 5 | $79 |
| Organon | 1 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Pharming Healthcare, Inc. | 2 | $34 |
| Phadia US Inc. | 2 | $32 |
| Biocryst Pharmaceuticals, Inc. | 1 | $28 |
| Octapharma USA, Inc. | 1 | $26 |
| Shire North American Group Inc | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| ADMA Biomanufacturing LLC | 1 | $20 |
| Mylan Specialty L.p. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Merck | 1 | $17 |
| Circassia Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,627 in reported general payments places this provider in the 80th percentile of 133 allergy & immunology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 15 | $40,997 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 17 | $2,431 |
| Azelastine Hcl | 25 | $696 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $397 |
| Ipratropium Bromide | 14 | $314 |
| Montelukast Sodium | 13 | $127 |
| Prednisone | 16 | $31 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Annandale
- Charles LaneLynchburg$1.4M
- Jacqueline Eghrari-SabetVienna$1M
- Eric KarlinWilliamsburg$522K
- Nicholas RiderRoanoke$227K
- Courtney BlairMc Lean$139K
- Andrew KimFredericksburg$104K
- Behnam DaghighLeesburg$99K
- Ananth ThyagarajanBurke$97K
- Larry BorishCharlottesville$92K
- Oral AlpanSpringfield$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.